Skip to main content
Clinical Trials/NL-OMON51239
NL-OMON51239WithdrawnNot Applicable

Further determining the possible association of skin irritation threshold and hypertrophic scar formation - Irritation threshold and hypertrophic scars-part two

Amsterdam UMC0 sites62 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Enrollment
62

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • Healthy human female volunteers who are prior to undergoing reduction
  • mammoplasties, are 18 years or older and legally competent.

Exclusion Criteria

  • * Fitzpatrick photo skin type IV or higher
  • * Skin disease, e.g. psoriasis, pemphigus vulgaris etc.
  • * Skin lesions, tattoos or substantial hair growth on the patch test site
  • * Pregnancy or lactation during the patch test
  • * Topical immunosuppressive treatment of the upper arm in the last 7 days
  • before the patch test
  • * Application of skin lotions or ointments on the upper arm in the last 6 weeks
  • before the patch test
  • * Abundant exposure of the upper arm to UVR during the patch test
  • * Systemic antibiotic treatment in the last 2 weeks before the patch test
  • * Systemic immunosuppressive treatment
  • * Immunological disorders: infectious disease, immune deficiencies, auto-immune
  • * Alcohol or drug abuse
  • * ASA classification 3 or higher
  • * Simultaneous participation in another clinical study that could interfere
  • with the outcome of this study
  • * Performing physical activities which cause heavy sweating, sauna, swimming or
  • extreme showers or baths during the patch test

Investigators

Sponsor
Amsterdam UMC

Similar Trials